| Date Filed | Type | Description |
| 08/22/2023 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 15,804 shares
@ $9.7, valued at
$153.3k
|
|
| 08/15/2023 |
4
| Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 3,075 shares
@ $0
Sold 1,241 shares
@ $138.1584, valued at
$171.5k
|
|
| 08/14/2023 |
144
| Form 144 - Report of proposed sale of securities: |
| 05/23/2023 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 15,804 shares
@ $11.21, valued at
$177.2k
|
|
| 03/03/2023 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 330,000 shares
@ $0 |
|
| 02/22/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/22/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2022 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 22,710 shares
@ $9.61, valued at
$218.2k
|
|
| 11/23/2021 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 11,404 shares
@ $8.36, valued at
$95.3k
|
|
| 08/24/2021 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 11,404 shares
@ $14.05, valued at
$160.2k
|
|
| 08/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/02/2021 |
4
| Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 2,246 shares
@ $0 |
|
| 05/24/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/10/2021 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 170,000 shares
@ $0 |
|
| 11/24/2020 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 13,946 shares
@ $17.21, valued at
$240k
|
|
| 08/24/2020 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 13,946 shares
@ $18.22, valued at
$254.1k
|
|
| 08/10/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/22/2020 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 13,946 shares
@ $26.67, valued at
$371.9k
|
|
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2020 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Granted 170,000 shares
@ $0
Granted 168,000 shares
@ $0 |
|
| 11/22/2019 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 8,678 shares
@ $17.6, valued at
$152.7k
|
|
| 08/22/2019 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 8,678 shares
@ $21.51, valued at
$186.7k
|
|
| 08/12/2019 |
4
| Winningham Rick E (Director) has filed a Form 4 on Jazz Pharmaceuticals plc|
Txns:
| Granted 1,920 shares
@ $0
Sold 726 shares
@ $135.6504, valued at
$98.5k
Granted 4,805 options to buy
@ $137.12, valued at
$658.9k
|
|
| 05/22/2019 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 8,678 shares
@ $19.84, valued at
$172.2k
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/07/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
5
| Form 5 - Annual statement of changes in beneficial ownership of securities: |
| 11/21/2018 |
4
| Winningham Rick E (CEO) has filed a Form 4 on Theravance Biopharma, Inc.|
Txns:
| Paid exercise price by delivering 15,557 shares
@ $24.79, valued at
$385.7k
|
|
|